Long-term Clinical Feasibility of the New Indwelling Provox Vega 20 Voice Prosthesis

NATerminatedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Total Laryngectomy
Interventions
DEVICE

Provox Vega voice prosthesis (20 Fr)

The current Provox2 voice prosthesis of laryngectomized patients will, when the patient comes in for a change, be replaced with a new, next generation Provox Vega voice prosthesis and insertion system

Trial Locations (1)

1066CX

Netherlands Cancer Institute, Amsterdam

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

The Netherlands Cancer Institute

OTHER

lead

Atos Medical AB

INDUSTRY

NCT00661570 - Long-term Clinical Feasibility of the New Indwelling Provox Vega 20 Voice Prosthesis | Biotech Hunter | Biotech Hunter